Morphology and Visual Acuity in Aflibercept and Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration in the VIEW Trials

Ophthalmology

Volumn 123, Issue 7, 2016, Pages 1521-1529

  Waldstein, Sebastian M ^a   Simader, Christian ^a   Staurenghi, Giovanni ^b   Chong, N Victor ^c   Mitchell, Paul ^d   Jaffe, Glenn J ^e   Lu, Chengxing ^f   Katz, Todd A ^f   Schmidt Erfurth, Ursula ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF SYDNEY   (Australia)

^e DUKE UNIVERSITY EYE CENTER   (United States)

^f BAYER CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLIBERCEPT; RANIBIZUMAB; ANGIOGENESIS INHIBITOR; HYBRID PROTEIN; VASCULOTROPIN RECEPTOR;

AGE RELATED MACULAR DEGENERATION; ARTICLE; CLINICAL FEATURE; DRUG EFFICACY; HUMAN; INTRARETINAL CYSTOID FLUID; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT DISEASE; RETINA DETACHMENT; RETINA EDEMA; SUBRETINAL FLUID; VISUAL ACUITY; AGED; ANALYSIS OF VARIANCE; CHOROIDAL NEOVASCULARIZATION; DRUG EFFECTS; FEMALE; INTRAVITREAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; RETINA; VERY ELDERLY; WET MACULAR DEGENERATION;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANGIOGENESIS INHIBITORS; CHOROIDAL NEOVASCULARIZATION; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RANIBIZUMAB; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; RETINA; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; WET MACULAR DEGENERATION;

EID: 84964838121     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2016.03.037     Document Type: Article

References (15)

1. P.J. Rosenfeld, D.M. Brown, J.S. Heier, and et al. Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 2006 1419 1431
2. D.M. Brown, P.K. Kaiser, M. Michels, and et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 355 2006 1432 1444
3. J.S. Heier, D.M. Brown, V. Chong, and et al. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration Ophthalmology 119 2012 2537 2548
4. U. Schmidt-Erfurth, V. Chong, A. Loewenstein, and et al. Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA) Br J Ophthalmol 98 2014 1144 1167
5. U. Schmidt-Erfurth, P.K. Kaiser, J.F. Korobelnik, and et al. Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies Ophthalmology 121 2014 193 201
6. M. Ritter, J. Elledge, C. Simader, and et al. Evaluation of optical coherence tomography findings in age-related macular degeneration: a reproducibility study of two independent reading centres Br J Ophthalmol 95 2011 381 385
7. U. Schmidt-Erfurth, S.M. Waldstein, G.G. Deak, and et al. Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration Ophthalmology 122 2015 822 832
8. S.M. Waldstein, A. Philip, R. Leitner, and et al. Correlation of 3-dimensionally quantified intraretinal and subretinal fluid with visual acuity in neovascular age-related macular degeneration JAMA Ophthalmol 134 2016 182 190
9. U. Schmidt-Erfurth, and S.M. Waldstein A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration Prog Retin Eye Res 50 2016 1 24
10. U. Jaffe, D.F. Martin, C.A. Toth, and et al. Macular morphology and visual acuity in the comparison of age-related macular degeneration treatment trials Ophthalmology 120 2013 1860 1870
11. M. Ritter, C. Simader, M. Bolz, and et al. Intraretinal cysts are the most relevant prognostic biomarker in neovascular age-related macular degeneration independent of the therapeutic strategy Br J Ophthalmol 98 2014 1629 1635
12. F.M. Penha, G. Gregori, C.A. Garcia Filho, and et al. Quantitative changes in retinal pigment epithelial detachments as a predictor for retreatment with anti-VEGF therapy Retina 33 2013 459 466
13. K.B. Freund, S.A. Zweifel, and M. Engelbert Do we need a new classification for choroidal neovascularization in age-related macular degeneration? Retina 30 2010 1333 1349
14. T. Schlegl, S.M. Waldstein, W.D. Vogl, and et al. Predicting semantic descriptions from medical images with convolutional neural networks Inf Process Med Imaging 24 2015 437 448
15. W.D. Vogl, S.M. Waldstein, B.S. Gerendas, and et al. Spatio-temporal signatures to predict retinal disease recurrence Inf Process Med Imaging 24 2015 152 163